Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 231

1.

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S.

Ann Intern Med. 2001 Apr 17;134(8):629-36.

PMID:
11304102
[PubMed - indexed for MEDLINE]
2.

Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors.

Mann JF.

Presse Med. 2005 Oct 22;34(18):1303-8. Review.

PMID:
16269994
[PubMed - indexed for MEDLINE]
Free Article
3.

Summaries for patients. Trial of a drug to decrease the risk for heart disease in patients with mild kidney failure.

[No authors listed]

Ann Intern Med. 2001 Apr 17;134(8):S-96. No abstract available.

PMID:
11324633
[PubMed - indexed for MEDLINE]
4.

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

Mann JF, Gerstein HC, Pogue J, Lonn E, Yusuf S.

Am J Cardiovasc Drugs. 2002;2(3):157-62. Review.

PMID:
14727978
[PubMed - indexed for MEDLINE]
6.

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.

Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S; HOPE Investigators.

Am J Kidney Dis. 2003 Nov;42(5):936-42.

PMID:
14582037
[PubMed - indexed for MEDLINE]
7.

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.

Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.

N Engl J Med. 2000 Jan 20;342(3):145-53. Erratum in: 2000 May 4;342(18):1376. N Engl J Med 2000 Mar 9;342(10):748.

PMID:
10639539
[PubMed - indexed for MEDLINE]
Free Article
8.

The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.

Sumner G, Salehian O, Yi Q, Healey J, Mathew J, Al-Merri K, Al-Nemer K, Mann JF, Dagenais G, Lonn E; HOPE Investigators.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):781-7. doi: 10.1111/j.1540-8167.2009.01440.x. Epub 2009 Feb 27.

PMID:
19298567
[PubMed - indexed for MEDLINE]
9.
10.

Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study.

Mann JF, Yi QL, Sleight P, Dagenais GR, Gerstein HC, Lonn EM, Bosch J; HOPE Investigators.

Clin Nephrol. 2005 Mar;63(3):181-7.

PMID:
15786818
[PubMed - indexed for MEDLINE]
11.

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Bakris GL, Weir MR.

Arch Intern Med. 2000 Mar 13;160(5):685-93.

PMID:
10724055
[PubMed - indexed for MEDLINE]
12.

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group.

Ann Intern Med. 2003 Apr 1;138(7):542-9.

PMID:
12667024
[PubMed - indexed for MEDLINE]
13.

The HOPE Study (Heart Outcomes Prevention Evaluation).

Sleight P.

J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. Review.

PMID:
11967789
[PubMed - indexed for MEDLINE]
14.

Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency.

Tonelli M, Moyé L, Sacks FM, Kiberd B, Curhan G; Cholesterol and Recurrent Events (CARE) Trial Investigators.

Ann Intern Med. 2003 Jan 21;138(2):98-104.

PMID:
12529091
[PubMed - indexed for MEDLINE]
15.

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation.

J Am Coll Cardiol. 2002 Aug 21;40(4):693-702.

PMID:
12204499
[PubMed - indexed for MEDLINE]
16.

Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients.

Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB.

Ann Intern Med. 2002 Oct 1;137(7):555-62.

PMID:
12353942
[PubMed - indexed for MEDLINE]
17.
18.

Acute myocardial infarction and renal dysfunction: a high-risk combination.

Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS.

Ann Intern Med. 2002 Oct 1;137(7):563-70.

PMID:
12353943
[PubMed - indexed for MEDLINE]
19.

Gemfibrozil for secondary prevention of cardiovascular events in mild to moderate chronic renal insufficiency.

Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC; Veterans' Affairs High-Density Lipoprotein Intervention Trial (VA-HIT) Investigators.

Kidney Int. 2004 Sep;66(3):1123-30.

PMID:
15327407
[PubMed - indexed for MEDLINE]
20.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk